Birner, C.; Mester, P.; Liebisch, G.; Höring, M.; Schmid, S.; Müller, M.; Pavel, V.; Buechler, C.
Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infect. Dis. Rep. 2024, 16, 806-819.
https://doi.org/10.3390/idr16050062
AMA Style
Birner C, Mester P, Liebisch G, Höring M, Schmid S, Müller M, Pavel V, Buechler C.
Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious Disease Reports. 2024; 16(5):806-819.
https://doi.org/10.3390/idr16050062
Chicago/Turabian Style
Birner, Charlotte, Patricia Mester, Gerhard Liebisch, Marcus Höring, Stephan Schmid, Martina Müller, Vlad Pavel, and Christa Buechler.
2024. "Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis" Infectious Disease Reports 16, no. 5: 806-819.
https://doi.org/10.3390/idr16050062
APA Style
Birner, C., Mester, P., Liebisch, G., Höring, M., Schmid, S., Müller, M., Pavel, V., & Buechler, C.
(2024). Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious Disease Reports, 16(5), 806-819.
https://doi.org/10.3390/idr16050062
